**Core Concept**
Mantle cell lymphoma (MCL) is a rare subtype of B-cell non-Hodgkin lymphoma characterized by the overexpression of cyclin D1 due to a translocation involving the cyclin D1 gene (CCND1) on chromosome 11q13. MCL cells often express specific surface antigens, known as markers, which help in its diagnosis.

**Why the Correct Answer is Right**
CD23 is a low-affinity IgE receptor that is typically expressed on mature B cells, but it is not a common marker for mantle cell lymphoma. MCL cells usually express a distinct set of antigens, including CD5, CD19, and CD20. CD5 is a cell surface receptor found on T cells and a subset of B cells, including MCL cells. CD19 and CD20 are both surface antigens expressed on mature B cells, and they are commonly used as markers for B-cell malignancies, including MCL.

**Why Each Wrong Option is Incorrect**
**Option A:** CD5 is indeed a marker for MCL, as it is expressed on a significant proportion of these cells.
**Option B:** CD19 is also a marker for MCL, as it is a surface antigen expressed on mature B cells, including those with MCL.
**Option C:** CD20 is another marker for MCL, as it is a surface antigen expressed on mature B cells, including those with MCL.

**Clinical Pearl / High-Yield Fact**
Mantle cell lymphoma often presents with systemic symptoms such as weight loss, night sweats, and fever, and it can involve multiple lymph node groups, including the Waldeyer's ring. The diagnosis of MCL is typically confirmed by flow cytometry, immunohistochemistry, and molecular studies, including FISH for the CCND1 translocation.

✓ Correct Answer: D. CD 23